SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

Melania Crypto is trending as community members voice intense skepticism, with many labeling the token a scam or a pump-and-dump scheme linked to the Trump family. Investors are actively debating the token's lack of utility, with many expressing regret over their holdings while others engage in heated political discourse surrounding the project's origins.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending as investors monitor a pending acquisition by Amazon, with the community actively speculating on the potential for a superior counter-offer from SpaceX to secure the company's highly valuable, non-shareable spectrum. While many shareholders are holding steady awaiting the finalized deal, others remain skeptical of the current valuation, looking for regulatory updates or strategic moves that could spark a bidding war.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

The community is actively discussing the potential of a Bitwise XRP ETF, while debates intensify over XRP's utility in institutional cross-border payments versus its recent price volatility and regulatory challenges. Traders are closely monitoring network activity, open interest, and the status of the Clarity Act as key indicators for the asset's future direction.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is facing significant community frustration and bearish sentiment as the token struggles near multi-year lows, leading many to debate whether current prices present a contrarian accumulation opportunity or a value trap. Investors are closely monitoring its performance relative to broader market movements while expressing deep concern over its lack of upward momentum compared to other altcoins.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Walt Disney is drawing significant attention as investors weigh the stock's long-term valuation against a mixed Q3 earnings report, while the companys recent box office successes and ongoing strategy shifts continue to fuel intense debate within the community regarding its future streaming and entertainment trajectory.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending as investors weigh strong federal contract wins and bullish analyst sentiment against broader concerns surrounding enterprise software spending. The community is actively debating whether ongoing sector rotation into AI infrastructure will continue to pressure SaaS stocks or if current valuations represent a significant long-term buying opportunity.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is attracting attention following an earnings report that showcased strong EBITDA growth and confirmed the onboarding of DaVita as a new commercial partner. While the community remains divided over the long-term impact of reimbursement changes, investors are closely debating the company's ability to maintain growth beyond these initial milestones.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA is trending as investors digest the introduction of new legislation aimed at GSE reform, fueling speculation about a potential end to conservatorship and a transition to a private IPO. The community remains divided, with long-term holders expressing frustration over persistent delays while others maintain high conviction that a monumental valuation shift is imminent under the current administration.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending as investors monitor ongoing institutional integrations with the DTCC and positive developments in real-world asset tokenization. The community remains divided between those accumulating through long-term belief in network utility and those frustrated by the persistent disconnect between adoption news and current price action.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is trending as market participants weigh reports of a potential $50 billion IPO for its AI chip subsidiary, Kunlunxin, against broader geopolitical concerns and recent US Department of Defense designations. Community sentiment remains sharply divided between those positioning for long-term growth through AI and autonomous driving advancements and others viewing the stock as a persistent value trap susceptible to regulatory and macro-economic headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NeuroSense Issues CEO Letter to Shareholders

NeuroSense Issues CEO Letter to Shareholders NeuroSense Issues CEO Letter to Shareholders PR Newswire CAMBRIDGE, Mass., Aug. 13, 2026 CAMBRIDGE, Mass., Aug. 13, 2026 /PRNewswire/ --NeuroSense Therapeutics Ltd.(NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on...

NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada

NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada PR Newswire CAMBRIDGE, Mass., Aug. 6, 2026 Final meeting minutes reflect alignment with...

NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS

NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS PR Newswire CAMBRIDGE, Mass., July 22, 2026 The planned submission follows alignment with Health Canada on the NDS pathway and is supported...

NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS"

NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS" NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS" PR Newswire CAMBRIDGE, Mass., July 6, 2026 Featuring renowned ALS expert Prof...

NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS

NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark...

NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease

NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease PR Newswire CAMBRIDGE, Mass., June 25, 2026 PrimeC was...

EverythingALS to Host NeuroSense in a Community Event Named: PrimeC - Connecting the Dots

EverythingALS to Host NeuroSense in a Community Event Named: PrimeC - Connecting the Dots EverythingALS to Host NeuroSense in a Community Event Named: PrimeC - Connecting the Dots PR Newswire CAMBRIDGE, Mass., June 22, 2026 CAMBRIDGE, Mass., June 22, 2026 /PRNewswire/ -- NeuroSense Therapeutics...

NeuroSense Granted South Korean Patent Covering PrimeC Composition for ALS

NeuroSense Granted South Korean Patent Covering PrimeC Composition for ALS NeuroSense Granted South Korean Patent Covering PrimeC Composition for ALS PR Newswire CAMBRIDGE, Mass., June 11, 2026 Patent claims cover PrimeC's proprietary formulation, manufacturing process and use in ALSExpands...

NeuroSense Therapeutics Receives Japanese Patent Grant for PrimeC Novel Composition

NeuroSense Therapeutics Receives Japanese Patent Grant for PrimeC Novel Composition NeuroSense Therapeutics Receives Japanese Patent Grant for PrimeC Novel Composition PR Newswire CAMBRIDGE, Mass., June 9, 2026 Patent Protection Extends Through 2042 following recent U.S., Australia and Brazil...

NeuroSense Announces Pricing of Insider-Led PIPE Financing

NeuroSense Announces Pricing of Insider-Led PIPE Financing NeuroSense Announces Pricing of Insider-Led PIPE Financing PR Newswire CAMBRIDGE, Mass., April 28, 2026 Financing led by CEO Alon Ben-Noon...

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). It also conducts testing of product candidates for the treatment of Parkinson's and Alzheimer's diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.

NeuroSense Therapeutics Ltd

Bullish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.4531
Prev Close	$0.4431
Open	$0.44
Dividend Yield	0.00%
50-Day Moving Average	$0.6536
Beta	0.77
Avg. Volume	284,737.57
PE Ratio	-0.78

52-Week High	$1.98
52-Week Low	$0.393
Market Capitalization	$17.11M
EPS (Annual)	-$0.4366
Price to Book	4.07
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info